A survey of family physicians pinpoints the reason for reticence in recommending medical marijuana to patients.

A 29-year-old Stanford dropout has developed a new biotechnology that threatens to give laboratory medicine its biggest shakeup in decades.

Multiple sclerosis specialists Mark Freedman and Patricia Coyle review the most recent developments in pharmacologic management of MS, including how best to sequence therapies.

From the 29th ECTRIMS conference, Dr. Aaron Miller discusses new data on potential contributing factors in multiple sclerosis.

FDA Commissioner Margaret Hamburg, MD, talks with Medscape at the National Health Research Forum in Washington, DC.

New data presented at ECTRIMS 2013 offer guidance on how to best use fingolimod in multiple sclerosis.

Drs. Fred Lublin and Robert Fox discuss 3 promising areas of multiple sclerosis research from ECTRIMS 2013 in Copenhagen, Denmark.

Being friends with your patient could distort your medical judgment. Ethicist Art Caplan tells us when such friendships are acceptable.

American Psychiatric Association President Dr. Jeffrey Lieberman on how government policies are out of sync with our country's medical needs.

A contorting approach to chronic low back pain appears safe and effective.